New York A 8979: Relates to reducing the use of PFAS chemicals in firefighting activities, and amending a chapter of the laws of 2019 in relation to the effectiveness thereof; repealer

Status: SUBSTITUTED BY S7167 (as of 2020-02-03)

State: New York · Session: 2019-2020 · Bill: A 8979

Sponsors: STECK

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A08979 Summary:

BILL NOA08979 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORSteck

&nbsp

COSPNSRGriffin, Stirpe, Schiavoni, Conrad, McDonald, Manktelow, DeStefano, Brook-Krasny, Gray, Brown K,
 Hevesi, Colton, Stern

&nbsp

MLTSPNSR

&nbsp

Add §392-k, Gen Bus L

&nbsp

Provides that no corporation, partnership, limited liability company, firm, online platform, or any other business entity doing business in this state shall knowingly sell, offer for sale, or deliver medetomidine to individuals without proof of its intended use for institutional, veterinary, or scientific purposes.

Go to top A08979 Actions:

BILL NOA08979 

&nbsp

08/13/2025referred to consumer affairs and protection

01/07/2026referred to consumer affairs and protection

Go to topA08979 Committee&nbspVotes:

Go to topA08979 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA08979 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 8979

 2025-2026 Regular Sessions

 IN ASSEMBLY

 August 13, 2025
 ___________

 Introduced by M. of A. STECK -- read once and referred to the Committee
 on Consumer Affairs and Protection

 AN ACT to amend the general business law, in relation to the sale of
 medetomidine

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The general business law is amended by adding a new section
 2 392-k to read as follows:
 3 § 392-k. Sale of medetomidine. 1. For purposes of this section, the
 4 term "medetomidine" shall mean a sedative used for its hypnotic and
 5 analgesic effects and that has been approved for use in humans and dogs.
 6 2. The provisions of this section shall apply to the sale, offer for
 7 sale, delivery, or distribution of all medetomidine regardless of the
 8 weight.
 9 3. No corporation, partnership, limited liability company, firm,
 10 online platform, or any other business entity doing business within this
 11 state shall knowingly sell, offer for sale, or deliver medetomidine to
 12 individuals without proof of its intended use for institutional, veteri-
 13 nary, or scientific purposes.
 14 4. No corporation, partnership, limited liability company, firm,
 15 online platform, or other business entity doing business within this
 16 state shall knowingly sell, offer for sale, or deliver medetomidine to
 17 individuals under the age of twenty-one.
 18 5. Any corporation, partnership, limited liability company, firm,
 19 online platform, or other business entity doing business within this
 20 state which knowingly sells, offers for sale, or distributes medetomi-
 21 dine shall require and retain sales records, proof of age, and proof of
 22 use from all purchasers.
 23 6. Any corporation, partnership, limited liability company, firm,
 24 online platform, or other business entity doing business within this
 25 state that violates the provisions of this section by knowingly selling,

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD13553-01-5

 A. 8979 2

 1 offering for sale, or delivering medetomidine shall be subject to a
 2 civil penalty of not more than three thousand dollars for a first
 3 violation, and sixty-five hundred dollars for each subsequent violation,
 4 recoverable in an action by the attorney general of the state of New
 5 York. All funds collected or received by the state from civil penalties
 6 imposed under this section shall be deposited in the New York state drug
 7 treatment and public education fund established pursuant to section
 8 ninety-nine-jj of the state finance law.
 9 § 2. This act shall take effect on the ninetieth day after it shall
 10 have become a law.

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps

View New York A 8979 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.